Kevin Tang $AUPH SEC Form 4 Insider Trading

Kevin Tang has filed a total of 12 insider trades in $AUPH since 2021. Their most recent trade was a purchase of 83,561 shares, made on Mar 02, 2026. Their largest trade was a purchase of 1.0 million shares, made on Aug 01, 2025. We estimate that they now own 12.2 million shares of $AUPH, worth an estimated $178.9 million.

Insider Trading at $AUPH

There have been a total of 90 insider trades reported at $AUPH since 2021, with 3.5 million shares purchased and 2.5 million shares sold. The most active insider traders in $AUPH stock have been Michael Robert Martin, Neil Solomons, and Robert Bindert Huizinga. The most recent trade was a purchase of 184,208 shares reported by KEVIN TANG (None), made on Mar 03, 2026.

$AUPH Executives and Stock Owners with Insider Trades

• Michael Robert Martin, Chief Business Officer

• Neil Solomons, Chief Medical Officer

• Robert Bindert Huizinga, EVP of Research

• Joseph M Miller, Chief Financial Officer

• Peter Greenleaf, Chief Executive Officer

• Stephen P. Robertson, EVP, General Counsel

• Greg Keenan, Chief Medical Officer

• Scott Michael Habig, Chief Commercial Officer

• Matthew Maxwell Donley, Chief Operating Officer

• Volker Knappertz, EVP, Research and Development

• Massimilano Colao, Chief Commercial Officer

• Matthew Maxwell Donley, EVP, Ops & Strategy

• Matthew Maxwell Donley, Ex VP, Intern'l Operations

• Matthew Maxwell Donley, Ex VP, Internal Operations

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.